Adaptive Biotechnologies Corp. stands out as a leader in immune-driven medicine, leveraging a proprietary immune profiling platform that provides unprecedented scale and precision in understanding our adaptive immune systems. The company collaborates with drug developers, clinicians, and academic researchers to apply these insights in developing products that aim to transform the diagnosis and treatment of diseases like cancer, autoimmune conditions, and infectious diseases. By harnessing the power of the adaptive immune system, Adaptive Biotechnologies is propelling a paradigm shift in medicine, making it a compelling place to work for those interested in cutting-edge healthcare solutions.